Skip to main content
OpenTrials

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,117 public trials 1,368 recruiting studies
Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Completed

Epidemiological Characteristics of Gastric and Pancreatic Cancers in Latin America

NCT05924789

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +12 more
Locations
  • Instituto de Oncología San Gerónimo Santa Fe, Santa Fe Province, Argentina
  • ÉTICA Clínica AMO - Assistência Multidisciplinar em Oncologia Salvador, Estado de Bahia, Brazil
  • HMV - Hospital Moinhos de Vento Porto Alegre, Rio Grande do Sul, Brazil
  • CEPON - Centro de Pesquisas Oncológicas Florianópolis, Santa Catarina, Brazil
View Trial Details
Completed

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901

NCT04805307

Conditions
Advanced Solid Tumor, Digestive System Diseases, Digestive System Neoplasms, +8 more
Locations
  • Sun Yat-sen University Cancer Center (SYSUCC) Guangzhou, Guangdong, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • West China Hospital of Sichuan University Chengdu, Sichuan, China
  • Affiliated Hospital of Hebei University Baoding, China
View all 32 locations
View Trial Details
Completed

LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors

NCT04666688

Conditions
Bile Duct Diseases, Bile Duct Neoplasms, Biliary Tract Diseases, +32 more
Locations
  • UCLA Los Angeles, California, United States
  • University of Colorado Hospital Denver, Colorado, United States
  • Sarah Cannon Research Institute at Health One Denver, Colorado, United States
  • Sarah Cannon Research Institute, Florida Cancer Specialists Sarasota, Florida, United States
View Trial Details
Completed

LY3214996 +/- HCQ in Pancreatic Cancer

NCT04386057

Conditions
Advanced Cancer, Digestive System Diseases, Digestive System Neoplasms, +7 more
Locations
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • The University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details
Completed

ATALANTE: Atezolizumab vs Placebo Phase III Study in Late Relapse Ovarian Cancer Treated With Chemotherapy+Bevacizumab

NCT02891824

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Krankenhaus der Barmherzigen Brüder Graz Graz, Austria
  • Medical University of Graz Graz, Austria
  • Medical University of Innsbruck Innsbruck, Austria
  • Medical University of Vienna Vienna, Austria
View all 75 locations
View Trial Details
Completed

Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers

NCT02349412

Conditions
Adenoma, Anxiety Disorder, Anxiety Disorders, +48 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Queen's Medical Center Honolulu, Hawaii, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois, United States
View all 23 locations
View Trial Details
Completed

Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction

NCT01638533

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +125 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
View Trial Details

Related conditions